Skip to main content
. 2020 Oct 3;9(10):322. doi: 10.3390/biology9100322

Figure 1.

Figure 1

Plasma expressions of the selected micro RNAs (miRs) and the markers of inflammation and oxidative stress in the patients with respiratory diseases. (a), Sarcopenia in pulmonary diseases was associated with altered expressions of miR-21, miR-34a, miR-133 and miR-206; (b), elevated levels of the markers of inflammation; (c), relatively unperturbed levels of the markers of oxidative stress. Dotted line represents the normalized expressions in healthy controls. Values are expressed as mean ± SD, * p < 0.05 vs. healthy controls (n = 68–75 per group). Interleukin-10, IL-10; transforming growth factor-beta 1, TGF-b1; c-c motif chemokine receptor 5, CCR5; c-x-c motif chemokine ligand 8, CXCL8; interleukin-6, IL-6; c-x-c motif chemokine ligand 2, CXCL2; adrenomedullin, ADM; superoxide dismutase-1, SOD1; glutathione synthetase, GSS; glutathione peroxidase-1, GPX1.